Visit LathamDrive – A new site with resources to help emerging companies grow.

Saad Khanani

Silicon Valley
  • 140 Scott Drive
  • Menlo Park, CA 94025
  • USA

Saad Khanani is an associate in the Silicon Valley office and a member of the firm’s Mergers & Acquisitions and Emerging Companies Practices. He previously worked in the Abu Dhabi and San Francisco offices.

Mr. Khanani represents emerging companies as well as venture capital and private equity firms, primarily in the technology and healthcare industries. His transactions practice focuses on general corporate counseling, venture capital financings, and mergers and acquisitions. His general company representation practice includes advising companies on formation, corporate governance, and commercial transactions.

At Columbia University School of Law, Mr. Khanani was a Kent Scholar and member of both the Columbia Business Law Review and the Faculty Rules Committee. Prior to joining Latham & Watkins, he worked at McKinsey & Company in Washington, D.C., where he advised senior leadership at Fortune 500 corporations and federal government agencies on strategic matters.

Mergers & Acquisitions

Mr. Khanani’s public and private mergers and acquisitions and strategic transaction practice has included representing:

  • Square, Inc. in various strategic acquisitions
  • Mellanox Technologies in its pending US$6.9 billion sale to NVIDIA Corporation
  • SRS Acquiom in its sale to Lovell Minnick Partners
  • Facebook in various strategic acquisitions
  • IXYS Corporation in its US$750 million sale to Littelfuse
  • Integrated Device Technology in its US$250 million acquisition of GigPeak
  • eResearchTechnology in its sale to Nordic Capital
  • Hightower in its strategic combination with VTS
  • Bridgepoint Advisors in its acquisition of Calypso Technology
Healthcare and Life Sciences
  • Landmark Health in its sale to General Atlantic
  • Relypsa, Inc. in its US$1.5 billion sale to Galenica AG
  • Encore Vision in its US$465 million acquisition by Novartis AG
  • Revolution Medicines in its acquisition of Warp Drive Bio and other strategic transactions
  • Alliance HealthCare Services in connection with the acquisition by Fujian Thai Hot Investment Co. of a majority of Alliance’s outstanding stock from Oaktree Capital and MTS Health Investors for US$102 million and a subsequent take-private transaction by Tahoe Investment Group Co. Ltd. for US$75 million
Venture Capital

Mr. Khanani regularly represents venture capital and growth equity firms in connection with private and public investments, acquisitions, and divestitures. His experience includes representing:

  • KKR in its investments in Ajax Health, Blue Sprig Pediatrics, Trilogy MedWaste, and other healthcare portfolio companies
  • Andreessen Horowitz in the US$154 million Series C financing of TripActions and various other investments in early stage technology companies
  • Dragoneer Investment Group in the US$400 million Series F financing of DoorDash and other investments
  • Eclipse Ventures in its investments in Bright Machines, Owlet Baby Care, 6 River Systems, Instrumental, June, Mavrx, and other early stage technology companies
  • GreatPoint Ventures in its investments in Even Financial and other early stage technology companies
  • Questa Capital in its investments in Epix Therapeutics and Cortica
  • 8VC in various investments in early stage healthcare and technology companies
  • Formation8 in various investments in early stage technology companies
Emerging Companies and Public Company Representation

Mr. Khanani represents public and private companies in general corporate governance matters, equity investments, and strategic transactions. His experience includes representing:

  • Bright Machines in its US$179 million Series A financing, joint venture with Flex, and other matters
  • Mellanox Technologies in its proxy contest defense against Starboard Value LP
  • Bebe in a strategic joint venture and sale of a minority interest
  • Soraa in its venture financings and strategic transactions
  • Calysta in its venture financings and strategic transactions
  • Synack in its Series C financing
  • Alliance Healthcare Series in its strategic transactions
  • Memphis Meats in its Series A financing
  • Instrumental in its Series A financing
  • Avalon Healthcare Solutions in various matters
  • Relievant MedSystems in its Series E financing
  • Singulex in its Series B financing and strategic transactions
Technology Transactions

Mr. Khanani also advises companies on their technology-related transactions. His experience includes representing: 

  • A leading audio streaming platform on an IT outsourcing project
  • A group of financial institutions on developing a mobile payment solution
  • A retail conglomerate on a large IT implementation project
  • A leading global airline on the outsourcing of their passenger services system
  • A government entity on developing, licensing, and implementing an online learning portal
  • A government entity on the procurement and implementation of a system to manage the provision of benefits and employment services
  • Telecom, media, and technology industry clients in various joint venture and acquisition transactions
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.